Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Arm Clinical Evaluation of Safety and Efficacy of the Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Subjects Eligible for Percutaneous Transluminal Coronary Angioplasty (PTCA) in China

NCT03471845 is registered in ClinicalTrials.gov with Medtronic Vascular as lead sponsor.

NCT NCT03471845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03471845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Arm Clinical Evaluation of Safety and Efficacy of the Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Subjects Eligible for Percutaneous Transluminal Coronary Angioplasty (PTCA) in China
Lead sponsor
Medtronic Vascular
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 30, 2018
Completion date
August 30, 2026
Enrollment
591 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arteriosclerosis, cardiovascular diseases, coronary artery disease, ischemic heart disease, stenotic coronary lesion